Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma-Reference-Cited by-同舟云学术

Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma

Published:2015-01-21 Issue:1 Volume:3 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

Pellegatta Serena,Valletta Lorella,Corbetta Cristina,Patanè Monica,Zucca Ileana,Riccardi Sirtori Federico,Bruzzone Maria Grazia,Fogliatto Gianpaolo,Isacchi Antonella,Pollo Bianca,Finocchiaro Gaetano

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40478-014-0180-0.pdf

Reference47 articles.

1. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–1812, doi:10.1126/science.1164382

2. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773, doi:10.1056/NEJMoa0808710

3. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739–744, doi:10.1038/nature08617

4. Saha SK, Parachoniak CA, Ghanta KS, Fitamant J, Ross KN, Najem MS, Gurumurthy S, Akbay EA, Sia D, Cornella H, Miltiadous O, Walesky C, Deshpande V, Zhu AX, Hezel AF, Yen KE, Straley KS, Travins J, Popovici-Muller J, Gliser C, Ferrone CR, Apte U, Llovet JM, Wong KK, Ramaswamy S, Bardeesy N (2014) Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer. Nature 513:110–114, doi:10.1038/nature13441

5. Losman J-AJ-A, Looper RE, Koivunen P, Lee S, Schneider RK, McMahon C, Cowley GS, Root DE, Ebert BL, Kaelin WG Jr (2013) (R)-2-Hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 339:1621–1625, doi:10.1126/science.1231677

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic accuracy of a machine learning-based radiomics approach of MR in predicting IDH mutations in glioma patients: a systematic review and meta-analysis;Frontiers in Oncology;2024-07-30

2. Treatment advances in high-grade gliomas;Frontiers in Oncology;2024-04-10

3. Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches;Frontiers in Pharmacology;2024-03-08

4. Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity;Heliyon;2024-01

5. Advances in molecular and imaging biomarkers in lower-grade gliomas;Expert Review of Neurotherapeutics;2023-11-20